Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CHRISTOPHER P KIRITSY Insider Profile
4 Followers
CHRISTOPHER P KIRITSY, Director at Pieris Pharmaceuticals, holds 20.00K shares in Pieris Pharmaceuticals (Ticker: PIRS), holds ― shares in HTG Molecular Diagnostics (Ticker: HTGMQ). Most recently, CHRISTOPHER P KIRITSY Bought ― shares of Pieris Pharmaceuticals on May 30, 2023 for an estimated value of 8.50K.
CHRISTOPHER P KIRITSY Pieris Pharmaceuticals (PIRS)Director
Pieris Pharmaceuticals (PIRS)
Director
Ranked #52,166 out of 98,624 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
-2.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that CHRISTOPHER P KIRITSY holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 09, 2017 - May 09, 2018
Return:+67.30%
The most profitable trade made by CHRISTOPHER P KIRITSY
CHRISTOPHER P KIRITSY's Trading History
Pieris Pharmaceuticals
May 30, 2023
Director
Informative Buy
8.50K
$234.40K
HTG Molecular Diagnostics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see CHRISTOPHER P KIRITSY's performance on stock
You May Also Like
CHRISTOPHER P KIRITSY insider profile FAQ
What is the percentage of profitable transactions made by CHRISTOPHER P KIRITSY?
The percentage of profitable transactions made by CHRISTOPHER P KIRITSY is 67%.
What is the average return per transaction made by CHRISTOPHER P KIRITSY?
The average return per transaction made by CHRISTOPHER P KIRITSY is -2.10%.
What stocks does CHRISTOPHER P KIRITSY hold?
CHRISTOPHER P KIRITSY holds: PIRS, HTGMQ stocks.
What was CHRISTOPHER P KIRITSY’s latest transaction?
CHRISTOPHER P KIRITSY latest transaction was an Informative Buy of $8.50K.
What was CHRISTOPHER P KIRITSY's most profitable transaction?
CHRISTOPHER P KIRITSY’s most profitable transaction was an Informative Buy of PIRS stock on May 9, 2017. The return on the trade was 67.30%.
What is CHRISTOPHER P KIRITSY's role in Pieris Pharmaceuticals?
CHRISTOPHER P KIRITSY's role in Pieris Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.